Altered miRNAs expression profiles and modulation of immune response genes and proteins during neonatal sepsis

Journal of Clinical Immunology

Volumn 34, Issue 3, 2014, Pages 340-348

  Chen, Jiande ^a   Jiang, Siyuan ^a   Cao, Yun ^a   Yang, Yi ^a  

^a CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

immune response; miRNA; modulation; neonatal sepsis

Indexed keywords

CD40 LIGAND; CHEMOKINE RECEPTOR CCR5; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; GAMMA INTERFERON; GRANULYSIN; GRANZYME B; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 16; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MICRORNA; MICRORNA 101; MICRORNA 1184; MICRORNA 141; MICRORNA 181A; MICRORNA 185; MICRORNA 29A; PERFORIN; PERFORIN 1; PROSTAGLANDIN ENDOPEROXIDE SYNTHASE 2; PROSTAGLANDIN SYNTHASE; PROTEIN; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; UNINDEXED DRUG; CYTOKINE; MESSENGER RNA; TRANSCRIPTOME;

ACINETOBACTER BAUMANNII; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DOWN REGULATION; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNE RESPONSE GENE; IMMUNOREGULATION; KLEBSIELLA; LEUKOCYTE; MALE; MICROARRAY ANALYSIS; NEWBORN; NEWBORN SEPSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; BIOLOGICAL MODEL; BLOOD; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNITY; IMMUNOLOGY; INFANT; RISK FACTOR; SEPSIS;

CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY; INFANT; INFANT, NEWBORN; MALE; MICRORNAS; MODELS, BIOLOGICAL; RISK FACTORS; RNA, MESSENGER; SEPSIS; TRANSCRIPTOME;

EID: 84898056643     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-014-0004-9     Document Type: Article

References (44)

1. Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin N Am. 2013;60:367-89.
2. Thaver D, Zaidi AK. Burden of neonatal infections in developing countries: a review of evidence from community-based studies. Pediatr Infect Dis J. 2009;28(1 Suppl):S3-9.
3. Wynn JL, Levy O. Role of innate host defenses in susceptibility to early-onset neonatal sepsis. Clin Perinatol. 2010;37:307-37.
4. Futata EA, Fusaro AE, de Brito CA, Sato MN. The neonatal immune system immunomodulation of infections in early life. Expert Rev Anti Infect Ther. 2012;10:289-98.
5. Belver L, Papavasiliou FN, Ramiro AR. MicroRNA control of lymphocyte differentiation and function. Curr Opin Immunol. 2011;23:368-73.
6. Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell. 2009;136:26-36.
7. Lu LF, Liston A. MicroRNA in the immune system, microRNA as an immune system. Immunology. 2009;127:291-8.
8. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215-33.
9. Liston A, Linterman M, Lu LF. MicroRNA in the adaptive immune system, in sickness and in health. J Clin Immunol. 2010;30:339-46.
10. Wang HJ, Zhang PJ, Chen WJ, Jie D, Dan F, Jia YH, et al. Characterization and identification of novel serum microRNAs in sepsis patients with different outcomes. Shock. 2013;39:480-7.
11. Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie L. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients' mortality: a prospective observational study. PLoS One. 2012;7:e38885.
12. Wang HJ, Zhang PJ, Chen WJ, Feng D, Jia YH, Xie LX. Four serum microRNAs identified as diagnostic biomarkers of sepsis. J Trauma Acute Care Surg. 2012;73:850-4.
13. Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie LX. Evidence for serum miR-15a and miR-16 levels as biomarkers that distinguish sepsis from systemic inflammatory response syndrome in human subjects. Clin Chem Lab Med. 2012;50:1423-8.
14. Wang JF, Yu ML, Yu G, Bian JJ, Deng XM, Wan XJ, et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun. 2010;394:184-8.
15. Schmidt WM, Spiel AO, Jilma B, Wolzt M, Müller M. In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem Biophys Res Commun. 2009;380:437-41.
16. Subspecialty Group of Neonatology Pediatric Society Chinese Medical Association; Editorial Board Chinese Journal of Pediatrics. [Protocol for diagnosis and treatment of neonatal septicemia]. Zhonghua Er Ke Za Zhi. 2003;41:897-9.
17. Skirecki T, Borkowska-Zielińska U, Złotorowicz M, Hoser G. Sepsis immunopathology: perspectives of monitoring and modulation of the immune disturbances. Arch Immunol Ther Exp (Warsz). 2012;60:123-35.
18. Aziz M, Jacob A, Yang WL, Matsuda A, Wang P. Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol. 2013;93:329-42.
19. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG. The pathogenesis of sepsis. Annu Rev Pathol. 2011;6:19-48.
20. Wynn J, Cornell TT, Wong HR, Shanley TP, Wheeler DS. The host response to sepsis and developmental impact. Pediatrics. 2010;125:1031-41.
21. Wynn JL, Neu J, Moldawer LL, Levy O. Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. J Perinatol. 2009;29:79-88.
22. Dai R, Ahmed SA. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res. 2011;157:163-79.
23. Gantier MP. New perspectives in MicroRNA regulation of innate immunity. J Interferon Cytokine Res. 2010;30(2):83-9.
24. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One. 2009;4:e7405.
25. Ishihara K, Sasaki D, Tsuruda K, Inokuchi N, Nagai K, Hasegawa H, et al. Impact of miR-155 and miR-126 as novel biomarkers on the assessment of disease progression and prognosis in adult T-cell leukemia. Cancer Epidemiol. 2012;36:560-5.
26. Wang K, Yuan Y, Cho JH, McClarty S, Baxter D, Galas DJ. Comparing the MicroRNA spectrum between serum and plasma. PLoS One. 2012;7:e41561.
27. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007;7:379-90.
28. Kollmann TR, Levy O, Montgomery RR, Goriely S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity. 2012;37:771-83.
29. Ygberg S, Nilsson A. The developing immune system - from foetus to toddler. Acta Paediatr. 2012;101:120-7.
30. Caldas JP, Marba ST, Blotta MH, Calil R, Morais SS, Oliveira RT. Accuracy of white blood cell count, C-reactive protein, interleukin-6 and tumor necrosis factor alpha for diagnosing late neonatal sepsis. J Pediatr (Rio J). 2008;84:536-42.
31. Sherwin C, Broadbent R, Young S, Worth J, McCaffrey F, Medlicott NJ, et al. Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis. Am J Perinatol. 2008;25:629-36.
32. Hodge G, Hodge S, Haslam R, McPhee A, Sepulveda H, Morgan E, et al. Rapid simultaneous measurement of multiple cytokines using 100 microl sample volumes-association with neonatal sepsis. Clin Exp Immunol. 2004;137:402-7.
33. Protonotariou E, Malamitsi-Puchner A, Rizos D, Sarandakou A, Makrakis E, Salamolekis E. Alterations in Thl/Th2 cytokine concentrations in early neonatal life. J Matern Fetal Neonatal Med. 2003;14:407-10.
34. Cabal-Hierro L, Lazo PS. Signal transduction by tumor necrosis factor receptors. Cell Signal. 2012;24:1297-305.
35. Contreras J, Rao DS. MicroRNAs in inflammation and immune responses. Leukemia. 2012;26:404-13.
36. Harper KA, Tyson-Capper AJ. Complexity of COX-2 gene regulation. Biochem Soc Trans. 2008;36:543-5.
37. Pham H, Ekaterina Rodriguez C, Donald GW, Hertzer KM, Jung XS, Chang HH, et al. miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cells. Biochem Biophys Res Commun. 2013;439:6-11.
38. O'Connell RM, Rao DS Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol. 2012;30:295-312.
39. Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell. 2007;129:147-61.
40. Stittrich AB, Haftmann C, Sgouroudis E, Kühl AA, Hegazy AN, Panse I, et al. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol. 2010;11:1057-62.
41. Ma F, Xu S, Liu X, Zhang Q, Xu X, Liu M, et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat Immunol. 2011;12:861-9.
42. Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest. 2012;122:2871-83.
43. Gatsiou A, Boeckel JN, Randriamboavonjy V, Stellos K. MicroRNAs in platelet biogenesis and function: implications in vascular homeostasis and inflammation. Curr Vasc Pharmacol. 2012;10:524-31.
44. Zhu QY, Liu Q, Chen JX, Lan K, Ge BX. MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages. J Immunol. 2010;185:7435-42.